Patrik Jonsson, the president of Lilly Bio-Medicines
Who knew? Dermira’s board kept watch as its stock price tracked Eli Lilly’s secret bidding on a $1.1B buyout
In just 8 days, from December 6 to December 14, the stock jumped from $7.88 to $12.70 — just under the initial $13 bid. There was no hard news about the company that would explain a rise like that tracking closely to the bid offer, raising the obvious question of whether insider info has leaked out to traders.
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
